Literature DB >> 24410785

CD8(+) T cells producing IL-3 and IL-5 in non-IgE-mediated eosinophilic diseases.

C Stoeckle1, H-U Simon.   

Abstract

The cytokines IL-5, IL-3, and GM-CSF are crucial for eosinophil development, survival, and function. To better understand their role in non-IgE-mediated eosinophilic diseases, we investigated plasma levels of these cytokines as well as cytokine expression in peripheral blood T cells. While we did not find any evidence for an involvement of T-cell-derived GM-CSF, some of these patients did show an increased proportion of IL-5- or IL-3-producing CD4(+) T cells. However, in a significant proportion of patients, IL-5-producing CD8(+) T cells, so-called Tc2 cells, which in healthy donors can only be detected at very low levels, were prominent. Furthermore, increased IL-3 production by CD8(+) T cells was also observed, strongly supporting the notion that CD8(+) T cells, not just CD4(+) T cells, must also be considered as a potential source of the cytokines promoting eosinophilia.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  IL‐3; IL‐5; T cells; eosinophils; non‐IgE

Mesh:

Substances:

Year:  2013        PMID: 24410785     DOI: 10.1111/all.12311

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  10 in total

1.  RhoH is a negative regulator of eosinophilopoiesis.

Authors:  Christina Stoeckle; Barbara Geering; Shida Yousefi; Saša Rožman; Nicola Andina; Charaf Benarafa; Hans-Uwe Simon
Journal:  Cell Death Differ       Date:  2016-10-14       Impact factor: 15.828

Review 2.  CD8+ Tc2 cells: underappreciated contributors to severe asthma.

Authors:  Timothy S C Hinks; Ryan D Hoyle; Erwin W Gelfand
Journal:  Eur Respir Rev       Date:  2019-11-20

Review 3.  Essential Mechanisms of Differential Activation of Eosinophils by IL-3 Compared to GM-CSF and IL-5.

Authors:  Stephane Esnault; Elizabeth A Kelly
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

Review 4.  Novel targeted therapies for eosinophil-associated diseases and allergy.

Authors:  Susanne Radonjic-Hoesli; Peter Valent; Amy D Klion; Michael E Wechsler; Hans-Uwe Simon
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-17       Impact factor: 13.820

5.  Clinical and Biological Markers in Hypereosinophilic Syndromes.

Authors:  Paneez Khoury; Michelle Makiya; Amy D Klion
Journal:  Front Med (Lausanne)       Date:  2017-12-22

6.  Fluctuations of Spleen Cytokine and Blood Lactate, Importance of Cellular Immunity in Host Defense Against Blood Stage Malaria Plasmodium yoelii.

Authors:  Takashi Imai; Kazutomo Suzue; Ha Ngo-Thanh; Suguri Ono; Wakako Orita; Haruka Suzuki; Chikako Shimokawa; Alex Olia; Seiji Obi; Tomoyo Taniguchi; Hidekazu Ishida; Luc Van Kaer; Shigeo Murata; Keiji Tanaka; Hajime Hisaeda
Journal:  Front Immunol       Date:  2019-09-25       Impact factor: 7.561

Review 7.  Pulmonary Eosinophils at the Center of the Allergic Space-Time Continuum.

Authors:  Sjoerd T T Schetters; Martijn J Schuijs
Journal:  Front Immunol       Date:  2021-11-15       Impact factor: 7.561

Review 8.  Recent advances of eosinophils and its correlated diseases.

Authors:  Zhang Tao; Hua Zhu; Jiateng Zhang; Zhiming Huang; Ze Xiang; Tu Hong
Journal:  Front Public Health       Date:  2022-07-25

Review 9.  The Cellular Functions of Eosinophils: Collegium Internationale Allergologicum (CIA) Update 2020.

Authors:  Hans-Uwe Simon; Shida Yousefi; Nina Germic; Isabelle C Arnold; Angela Haczku; Alexander V Karaulov; Dagmar Simon; Helene F Rosenberg
Journal:  Int Arch Allergy Immunol       Date:  2019-11-29       Impact factor: 2.749

10.  Synergistic activation of pro-inflammatory type-2 CD8+ T lymphocytes by lipid mediators in severe eosinophilic asthma.

Authors:  Bart Hilvering; Timothy S C Hinks; Linda Stöger; Emanuele Marchi; Maryam Salimi; Rahul Shrimanker; Wei Liu; Wentao Chen; Jian Luo; Simei Go; Timothy Powell; Jennifer Cane; Samantha Thulborn; Ayako Kurioka; Tianqi Leng; Jamie Matthews; Clare Connolly; Catherine Borg; Mona Bafadhel; Christian B Willberg; Adaikalavan Ramasamy; Ratko Djukanović; Graham Ogg; Ian D Pavord; Paul Klenerman; Luzheng Xue
Journal:  Mucosal Immunol       Date:  2018-06-15       Impact factor: 7.313

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.